Physician profile
Patrick Karr
NPI 1386679991
$2,948.43
in general payments reported to CMS, 2019-2025
29 companies · $474 in 2025
The $474 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $234 · 2021: $751 · 2022: $351 · 2023: $400 · 2024: $348 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,221.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $620.13 | 2019-2025 | |
| Astellas Pharma US INC | $263.41 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $226.10 | 2019-2024 | Myosure Tissue Removal Device, Thinprep 2000 Processor, Aptima |
| Mayne Pharma Commercial LLC | $170.31 | 2021 | |
| Minerva Surgical, INC | $165.15 | 2021-2024 | |
| Pfizer INC. | $157.05 | 2019-2024 | |
| Therapeuticsmd, INC. | $139.31 | 2019-2022 | |
| Novo Nordisk INC | $133.52 | 2020-2024 | Wegovy |
| Avion Pharmaceuticals | $132.43 | 2020-2022 | |
| Exeltis, USA INC. | $132.35 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $113.50 | 2019-2022 | |
| Ethicon US, LLC | $99.09 | 2019-2025 | Surgicel Nu-Knit, Dermabond Prineo, Stratafix |
| Channel Medsystems, INC. | $85.85 | 2022-2023 | |
| Biogen, INC. | $81.51 | 2025 | Zurzuvae |
| Amgen INC. | $65.29 | 2024-2025 | Evenity, Prolia, Prolia |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $55.85 | 2020-2021 | |
| Coopersurgical, INC. | $53.73 | 2023-2025 | Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Sumitomo Pharma America, INC. | $44.43 | 2023 | Myfembree |
| Avanos Medical | $27.91 | 2021-2025 | On-Q Pump and Accessories |
| Organon LLC | $27.18 | 2024 | |
| Currax Pharmaceuticals LLC | $24.85 | 2021-2022 | |
| Covidien Lp | $23.22 | 2020 | |
| Meditrina | $19.27 | 2023 | |
| Allergan, INC. | $15.72 | 2019 | |
| Merck Sharp & Dohme LLC | $15.49 | 2019 | |
| Sanara Medtech INC. | $15.10 | 2024 | Celleraterx |
| Microline Surgical INC | $14.73 | 2025 | |
| Hologic INC | $13.41 | 2021 | |
| Stryker Corporation | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Karr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.